Bobak R. Azamian, President/CEO and Board Chair at Tarsus Pharmaceuticals, Inc. (TARS), sold 6,000 shares at $50.00 ($300K) on 2025-03-24, disclosed to the SEC on 2025-03-26.
Open-market sale of $300k TARS by President/CEO and Board Chair. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| TARS | SELL | 2026-06-22 | $615K | — | Filing → |
| TARS | SELL | 2026-03-19 | $2.4M | — | Filing → |
| TARS | SELL | 2025-12-30 | $944K | — | Filing → |